Ryan Dorton
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Peptidase Inhibition and Analysis 2
- HER2/EGFR in Cancer Research 1
-
- Folate and B Vitamins Research 3
- Co-authors
- Joseph A. Reddy (13 shared papers)Christopher P. Leamon (13 shared papers)Marilynn Vetzel (12 shared papers)Elaine M. Westrick (9 shared papers)Iontcho R. Vlahov (10 shared papers)Nikki L. Parker (4 shared papers)Paul J. Kleindl (4 shared papers)Hari Krishna R. Santhapuram (4 shared papers)
- Journals
- Cancer Research (3 papers)Molecular Pharmaceutics (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Bioconjugate Chemistry (2 papers)Scientific Reports (1 paper)
- Partner nations
- United States
In The Last Decade
Ryan Dorton
14 papers receiving 686 citations
Peers
Comparison fields: 5 of 68
- Biomaterials 128
- Oncology 203
- Radiology, Nuclear Medicine and Imaging 135
- Rheumatology 82
- Organic Chemistry 159
Countries citing papers authored by Ryan Dorton
This map shows the geographic impact of Ryan Dorton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Dorton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Dorton more than expected).
Fields of papers citing papers by Ryan Dorton
This network shows the impact of papers produced by Ryan Dorton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Dorton. The network helps show where Ryan Dorton may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Dorton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 156 | |
| 2 | 2007 | 100 | |
| 3 | 2008 | 85 | |
| 4 | 2008 | 65 | |
| 5 | 2009 | 59 | |
| 6 | 2014 | 58 | |
| 7 | 2010 | 45 | |
| 8 | 2018 | 37 | |
| 9 | 2019 | 31 | |
| 10 | 2006 | 26 | |
| 11 | 2014 | 23 | |
| 12 | 2016 | 16 | |
| 13 | 2017 | 10 | |
| 14 | Folate receptor targeted anti-tumor activity of EC-0225, a folate-targeted dual drug conjugate | 2006 | 1 |
About Ryan Dorton
Ryan Dorton is a scholar working on Oncology, Rheumatology, Organic Chemistry, Pediatrics, Perinatology and Child Health and Complementary and alternative medicine, having authored 14 papers that have together received 712 indexed citations. Recurring topics across this work include Folate and B Vitamins Research (3 papers), Cancer Treatment and Pharmacology (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), Click Chemistry and Applications (2 papers), Cancer therapeutics and mechanisms (2 papers), Peptidase Inhibition and Analysis (2 papers), Glycosylation and Glycoproteins Research (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Biomaterials (128 citations), Oncology (203 citations), Radiology, Nuclear Medicine and Imaging (135 citations), Rheumatology (82 citations) and Organic Chemistry (159 citations). Ryan Dorton has collaborated with scholars based in United States. Frequent co-authors include Joseph A. Reddy, Christopher P. Leamon, Marilynn Vetzel, Elaine M. Westrick, Iontcho R. Vlahov, Nikki L. Parker, Paul J. Kleindl, Hari Krishna R. Santhapuram, Melissa Nelson and Le-Cun Xu. Their work appears in journals such as Cancer Research, Molecular Pharmaceutics, Journal of Pharmacology and Experimental Therapeutics, Bioconjugate Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.